Katie Stricklin concentrates her practice in all aspects of complex civil litigation, including life sciences, product liability and general liability defense matters. Katie has been involved in the representation of a wide variety of clients, including manufacturers, suppliers, retailers, makers of medical devices, pharmaceutical and dietary/herbal supplements. She has experience with multiple-party litigation, and has participated in successful resolution of these types of claims through dispositive motions, mediations, settlement conferences and trial.
- Various USDC cases in Hawaii v. USP Labs – Dismissal of a product packager from a series of multi-plaintiff cases involving allegations of bodily injuries and death claimed to have been caused by ingestion of a dietary supplement.
- Defense judgment on behalf of a former chemical distribution company in an environmental contamination case venued in federal district court in California. Plaintiff alleged PCE contamination on a site in a redevelopment zone in Pomona.
- Defense verdict on behalf of a general contractor in a construction defect case where plaintiff sought millions for alleged deficiencies in his high-end Laguna Beach home.
- Dismissal of a generic pharmaceutical manufacturer in a personal injury product liability case where plaintiff alleged ingestion of prescription medication caused Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
- Summary judgment granted in favor of an owner/developer of a large commercial retail center. Multi-plaintiff claims were based on alleged toxic exposure and damages in excess of $1.6 million dollars.
- Dismissal of medical device manufacturer in a personal injury product liability case where plaintiff sought damages for permanent injuries to a minor allegedly resulting from a defective circumcision clamp.
- Dismissal of a medical device manufacturer in personal injury products liability and fraud action where plaintiff sought damages related to a spinal fusion procedure.
- Summary judgment granted in favor of medical device manufacturer in product liability action.
- “Claims and Litigation Trends in the Life Sciences Industry”
- “The Nuts and Bolts of Construction Litigation”
- Walsworth Publishes 2021 Life Sciences Year In Review
- Walsworth Publishes 2020 Life Sciences Year In Review
- Walsworth Publishes 2019 Life Sciences Year In Review
- Walsworth Honored at OCWLA Gala for Advancement of Women Award
- Walsworth Obtains Judgment in Product Liability Action
- Walsworth Announces 2019 Partner Class
- Walsworth Publishes 2018 Year-End Life Sciences Update
- Walsworth Publishes 2017 Year-End Life Sciences Update
- Medical Device Sales Reps in the Operating Room: An Asset or a Liability?
- Walsworth Publishes 2016 Year-End Life Sciences Update
- Walsworth Publishes 2016 Mid-Year Life Sciences Update
- Losing Its Bite? The Erosion of FDA Power Over Promotion of Off-Label Drug Use
- A Second Bite at the Apple? Recovery for Wrongful Death After Settling an Underlying Personal Injury Claim